SCHEMBL5223654

SCHEMBL5223654

CC(C)CCCC(C)NC[C@@H](O)[C@H](Cc1cccs1)N(C(=O)O)C(C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.38
BACE1 P56817 3/20 0.38
CTSD P07339 1/20 0.38
BACE2 Q9Y5Z0 1/20 0.38
CYP2C19 P33261 1/20 0.36
POLB P06746 1/20 0.35
NPC1 O15118 3/20 0.34
LMNA P02545 3/20 0.34
CTSC P53634 2/20 0.34
HTT P42858 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
ALDH1A1 P00352 1/20 0.34
GAA P10253 1/20 0.34
HPGD P15428 1/20 0.34
RIPK1 Q13546 1/20 0.33
CTSS P25774 1/20 0.33
CTSK P43235 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5223660 1.00 RAB9A (0.38) RAB9ABACE1CTSDBACE2CYP2C19
SCHEMBL5226207 0.82 CTSD (0.38) BACE1CTSDBACE2CTSSCTSK
SCHEMBL5226201 0.82 CTSD (0.38) BACE1CTSDBACE2CTSSCTSK
SCHEMBL5223208 0.82 CTSD (0.38) RAB9ABACE1CTSDBACE2NPC1
SCHEMBL5223196 0.82 CTSD (0.38) RAB9ABACE1CTSDBACE2NPC1
SCHEMBL5224498 0.82 CTSD (0.34) BACE1CTSDBACE2
SCHEMBL5224505 0.82 CTSD (0.34) BACE1CTSDBACE2
Hydrochloric Acid SCHEMBL5226221 0.76 RAB9A (0.42) RAB9ABACE1CTSDBACE2CYP2C19
SCHEMBL5221569 0.73 NPC1 (0.42) RAB9ACYP2C19NPC1LMNA
SCHEMBL5221576 0.73 NPC1 (0.42) RAB9ACYP2C19NPC1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567488-B1 HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE GLAXO GROUP LTD (GB) 2007-02-21 EP disclosed